KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Exchange Rate Effect: 2013-2025

Historic Exchange Rate Effect for Xenon Pharmaceuticals (XENE) over the last 11 years, with Sep 2025 value amounting to -$6,000.

  • Xenon Pharmaceuticals' Exchange Rate Effect fell 111.11% to -$6,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$595,000, marking a year-over-year decrease of 121.19%. This contributed to the annual value of -$1.7 million for FY2024, which is 544.68% down from last year.
  • Xenon Pharmaceuticals' Exchange Rate Effect amounted to -$6,000 in Q3 2025, which was down 100.95% from $632,000 recorded in Q2 2025.
  • Over the past 5 years, Xenon Pharmaceuticals' Exchange Rate Effect peaked at $814,000 during Q4 2022, and registered a low of -$2.7 million during Q3 2022.
  • Over the past 3 years, Xenon Pharmaceuticals' median Exchange Rate Effect value was -$6,000 (recorded in 2025), while the average stood at -$66,727.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first skyrocketed by 1,079.71% in 2022, then slumped by 722.03% in 2024.
  • Xenon Pharmaceuticals' Exchange Rate Effect (Quarterly) stood at $69,000 in 2021, then skyrocketed by 1,079.71% to $814,000 in 2022, then plummeted by 69.78% to $246,000 in 2023, then tumbled by 570.33% to -$1.2 million in 2024, then plummeted by 111.11% to -$6,000 in 2025.
  • Its Exchange Rate Effect was -$6,000 in Q3 2025, compared to $632,000 in Q2 2025 and -$64,000 in Q1 2025.